Jefferies Financial Group Inc. Celldex Therapeutics, Inc. Call Options Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $2.62 Million - $3.58 Million	-75,400 Reduced 73.42%	27,300 $982,000
Q4 2022 Sep 21, 2023	BUY	$27.78 - $45.38 $2.85 Million - $4.66 Million	102,700 New	102,700 $4.58 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $2.85 Million - $4.66 Million	102,700 New	102,700 $4.58 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.18B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.